Clinical Trial: Safety Study of Intracerebral Topotecan for Recurrent Brain Tumors

Share this article:
Clinical Trial: Safety Study of Intracerebral Topotecan for Recurrent Brain Tumors

Sponsor and Collaborators

Columbia University

Contact
Contact: Candix Yanes, BSN/RN
(212) 305-1282
cy2162@columbia.edu

Principal Investigator
Jeffrey Bruce, MD Columbia University

ClinicalTrials.gov Identifier
NCT00308165
Share this article:
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters


What is this?

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs

More in Brain Cancer Clinical Trials

Clinical Trial: Assessment of Eloquent Function in Brain Tumor Patients

Clinical trial focusing on eloquent function in brain tumor patients. Assessment of Eloquent Function in Brain Tumor Patients

Clinical Trial: MRI and Diffusion Tensor Imaging of the Motor and Language ...

Clinical trial focusing on optimizing brain tumor resection. MRI and Diffusion Tensor Imaging of the Motor and Language Pathways to Optimize Brain Tumor Resection.

Clinical Trial: Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM ...

Clinical trial focusing on DCVax®-L and newly diagnosed GBM brain cancer. Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer